[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644576":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Giuseppe Petralia, PhD","CONTACT","+39 0257489037","giuseppe.petralia@ieo.it",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"European Institute of Oncology, Milan","RECRUITING","Milan","Mi","20141","Italy",{"type":23,"coordinates":24},"Point",[25,26],12.59836,42.78235,{"lat":26,"lon":25},[29,33],{"name":30,"role":11,"phone":31,"phoneExt":7,"email":32},"Lorenzo Conti, Researcher","+39 0294371083","Lorenzo.Conti@ieo.it",{"name":34,"role":35,"phone":7,"phoneExt":7,"email":7},"Giusppe Petralia, PhD","PRINCIPAL_INVESTIGATOR",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100644576",false,"NCT07671846","Patient Anxiety During Magnetic Resonance Imaging","Italian Translation and Cross-cultural Validation of a Questionnaire Evaluating Patient Anxiety During Magnetic Resonance Imaging: the Magnetic Resonance Imaging-Anxiety Questionnaire (MRI-AQ)","MRI-AQ","Inclusion Criteria:\n\n* Cancer patients who will perform a WB-MRI in their clinical path\n* Age ≥ 18 years\n* Patients able to speak and read the local language(s) fluently.\n* Patients with no concomitant neurological or psychiatric disorders.\n* Acceptance and signature of informed consent\n\nExclusion Criteria:\n\n* Absolute contraindication to WB-MRI\n* Previous cancer-related medical treatments or other treatments that could have altered patients' cognition","ALL","18 Years",{"count":48,"type":49},175,"ESTIMATED","OBSERVATIONAL","This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.",[53],"Cancer",[55,56],"Magnetic Resonance Imaging","Patient anxiety","2026-06-25",{"date":59,"type":60},"2026-06-26","ACTUAL",{"date":62,"type":60},"2026-05-06",{"date":64,"type":49},"2027-02-28",{"name":5,"class":6},1]